Sargent Investment Group, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 96 filers reported holding RELMADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sargent Investment Group, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$64,380
-36.5%
21,460
-1.6%
0.01%
-40.9%
Q1 2024$101,454
+108.7%
21,818
+34.6%
0.02%
+83.3%
Q3 2023$48,618
+19.7%
16,206
-1.8%
0.01%
+20.0%
Q2 2023$40,605
+19.7%
16,506
+15.3%
0.01%
+11.1%
Q1 2023$33,93114,3170.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders